Skip to Main Content

This session highlights successful industry and patient advocacy collaborations around the globe in the past year and examines how the global patient advocacy community can build upon those successes to create a new normal of advocacy in the Covid-19 era. Watch the video above to learn more.


  • Julie Gerberding, MD, MPH, Executive Vice President & Chief Patient Officer, Merck & Co, Inc.
  • Nicholas Brooke, Executive Director, Patient Focused Medicines Development
  • Ratna Devi, Chair, International Alliance of Patient Organizations
  • Eva Maria Ruiz de Castilla, Latin America Patient Academy